Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
71.50
+4.00 (5.93%)
Sep 23, 2026, 9:10 AM CET

STO:IBT.B Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9096807221,212561750
Market Cap Growth
-6.25%-5.78%-40.44%116.00%-25.15%-40.36%
Enterprise Value
801515496845193360
Last Close Price
67.5050.5053.6090.0050.0066.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--180517.0315745.8246775.77-
PB Ratio
17.156.464.243.971.691.90
P/TBV Ratio
17.156.464.243.971.691.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--123968.0310976.8916081.52-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.05-1.37-1.31-1.08-1.01-0.98
Net Debt / FCF Ratio
1.701.991.983.253.916.95
Quick Ratio
1.662.613.297.2718.8529.34
Current Ratio
1.672.723.337.4018.9330.03
Return on Equity (ROE)
-87.44%-47.29%-57.59%-38.65%-18.01%-10.77%
Return on Assets (ROA)
-33.89%-21.49%-30.75%-24.01%-10.85%-6.50%
Return on Capital Employed (ROCE)
-160.30%-65.50%-85.40%-44.10%-19.80%-11.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.01%-9.58%-18.96%-10.15%-11.66%-6.00%
FCF Yield
-7.05%-10.63%-15.67%-8.35%-15.29%-7.42%
Buyback Yield / Dilution
---8.95%-10.14%--